Outset Medical
154 hedge funds and large institutions have $1.16B invested in Outset Medical in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 25 closing their positions.
149% more call options, than puts
Call options by funds: $588K | Put options by funds: $236K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
21% more capital invested
Capital invested by funds: $957M → $1.16B (+$201M)
12% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 51
0.05% more ownership
Funds ownership: 7.13% → 7.18% (+0.05%)
5% less funds holding
Funds holding: 162 → 154 (-8)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Top Buyers
Top Sellers
| 1 |
PVI
Pura Vida Investments
New York
|
-$7.65M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.96M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$6.58M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$6.21M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$5.98M |
OM Hedge Fund Activity: Q2 2023 in Review
154 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2023, worth a combined $1.16B — up 21% from $957M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of OM and 18 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 57 added.
The largest buyer was Millennium Management, adding an estimated $31.4M. The largest seller was Pura Vida Investments, cutting an estimated $7.65M.
- 154 institutional investors held Outset Medical (OM) as of Q2 2023, down from 162 in Q1 2023.
- Funds reported $1.16B of Outset Medical stock for Q2 2023, up 21% quarter-over-quarter.
- 18 funds opened new Outset Medical positions in Q2 2023 and 25 closed out, a net change of -7 holders.
- The largest Outset Medical buyer in Q2 2023 was Millennium Management, an estimated $31.4M added.
- The largest Outset Medical seller in Q2 2023 was Pura Vida Investments, an estimated $7.65M sold.
Based on aggregated 13F filings for Q2 2023.